Nadeem Q. Mirza

Dr. Mirza is a seasoned executive physician with 28 years of experience in solid tumors, hematologic malignancies, and bone marrow transplantation, including 12 years of clinical research at MD Anderson Cancer Center and 16 years of clinical development and medical affairs in the biopharmaceutical industry. Dr. Mirza launched several oncology therapies including Campath®, Abraxane®, Nexavar®, Clolar®, Zaltrap®, Venclexta®, and Copiktra®. Dr. Mirza previously served as Chief Medical Advisor with TRIGR Therapeutics, Senior Vice President, Corporate Medical Affairs at Verastem Oncology, and Global Head, Hematology and Solid Tumors at Abbvie Oncology. As Vice President, Head of Oncology, North America Medical Affairs at Sanofi Oncology Dr. Mirza was responsible for the medical affairs program that supported 12 products across several oncology indications. Dr. Mirza conducted clinical research at MD Anderson Cancer Center, Houston, Texas from 1992 - 2004.

Dr. Mirza earned a medical degree from the University of Punjab (Lahore, Pakistan) and a Master of Public Health from the University of Texas.